Chien, W.W. et al. Gene therapy restores hair cell stereocilia morphology in inner ears of deaf whirler mice. Mol. Ther. 24, 17–25 (2016).
Askew, C. et al. Tmc gene therapy restores auditory function in deaf mice. Sci. Transl. Med. 7, 295ra108 (2015).
Akil, O. et al. Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. Neuron 75, 283–293 (2012).
Boughman, J.A., Vernon, M. & Shaver, K.A. Usher syndrome: definition and estimate of prevalence from two high-risk populations. J. Chronic Dis. 36, 595–603 (1983).
Smith, R.J. et al. Clinical diagnosis of the Usher syndromes. Am. J. Med. Genet. 50, 32–38 (1994).
Vernon, M. Usher's syndrome--deafness and progressive blindness. Clinical cases, prevention, theory and literature survey. J. Chronic Dis. 22, 133–151 (1969).
Weil, D. et al. Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 374, 60–61 (1995).
Weston, M.D. et al. Myosin VIIA mutation screening in 189 Usher syndrome type 1 patients. Am. J. Hum. Genet. 59, 1074–1083 (1996).
Adato, A. et al. Mutation profile of all 49 exons of the human myosin VIIA gene, and haplotype analysis, in Usher 1B families from diverse origins. Am. J. Hum. Genet. 61, 813–821 (1997).
Liu, X.Z., Newton, V.E., Steel, K.P. & Brown, S.D. Identification of a new mutation of the myosin VII head region in Usher syndrome type 1. Hum. Mutat. 10, 168–170 (1997).
Bitner-Glindzicz, M. et al. A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene. Nat. Genet. 26, 56–60 (2000).
Verpy, E. et al. A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C. Nat. Genet. 26, 51–55 (2000).
Bolz, H. et al. Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D. Nat. Genet. 27, 108–112 (2001).
Bork, J.M. et al. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am. J. Hum. Genet. 68, 26–37 (2001).
Ahmed, Z.M. et al. Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F. Am. J. Hum. Genet. 69, 25–34 (2001).
Alagramam, K.N. et al. The mouse Ames waltzer hearing-loss mutant is caused by mutation of Pcdh15, a novel protocadherin gene. Nat. Genet. 27, 99–102 (2001a).
Alagramam, K.N. et al. Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum. Mol. Genet. 10, 1709–1718 (2001b).
Weil, D. et al. Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin. Hum. Mol. Genet. 12, 463–471 (2003).
Riazuddin, S. et al. Alterations of the CIB2 calcium- and integrin-binding protein cause Usher syndrome type 1J and nonsyndromic deafness DFNB48. Nat. Genet. 44, 1265–1271 (2012).
Boëda, B. et al. Myosin VIIa, harmonin and cadherin 23, three Usher I gene products that cooperate to shape the sensory hair cell bundle. EMBO J. 21, 6689–6699 (2002).
Lefèvre, G. et al. A core cochlear phenotype in USH1 mouse mutants implicates fibrous links of the hair bundle in its cohesion, orientation and differential growth. Development 135, 1427–1437 (2008).
Grillet, N. et al. Harmonin mutations cause mechanotransduction defects in cochlear hair cells. Neuron 62, 375–387 (2009).
Michalski, N. et al. Harmonin-b, an actin-binding scaffold protein, is involved in the adaptation of mechanoelectrical transduction by sensory hair cells. Pflugers Arch. 459, 115–130 (2009).
Gregory, F.D. et al. Harmonin inhibits presynaptic Cav1.3 Ca2 channels in mouse inner hair cells. Nat. Neurosci. 14, 1109–1111 (2011).
Gregory, F.D., Pangrsic, T., Calin-Jageman, I.E., Moser, T. & Lee, A. Harmonin enhances voltage-dependent facilitation of Cav1.3 channels and synchronous exocytosis in mouse inner hair cells. J. Physiol. (Lond.) 591, 3253–3269 (2013).
Lentz, J.J. et al. Deafness and retinal degeneration in a novel USH1C knock-in mouse model. Dev. Neurobiol. 70, 253–267 (2010).
Lentz, J., Pan, F., Ng, S.S., Deininger, P. & Keats, B. Ush1c216A knock-in mouse survives Katrina. Mutat. Res. 616, 139–144 (2007).
Lentz, J. et al. The USH1C 216G→A splice-site mutation results in a 35-base-pair deletion. Hum. Genet. 116, 225–227 (2005).
Landegger, L. et al. A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear. Nat. Biotechnol. http://dx.doi.org/10.1038/nbt.3781 (2017).
Lentz, J.J. et al. Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness. Nat. Med. 19, 345–350 (2013).
Gale, J.E., Marcotti, W., Kennedy, H.J., Kros, C.J. & Richardson, G.P. FM1-43 dye behaves as a permeant blocker of the hair-cell mechanotransducer channel. J. Neurosci. 21, 7013–7025 (2001).
Meyers, J.R. et al. Lighting up the senses: FM1-43 loading of sensory cells through nonselective ion channels. J. Neurosci. 23, 4054–4065 (2003).
Géléoc, G.S. & Holt, J.R. Developmental acquisition of sensory transduction in hair cells of the mouse inner ear. Nat. Neurosci. 6, 1019–1020 (2003).
Zinn, E. et al. In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector. Cell Rep. 12, 1056–1068 (2015).
Kho, S.T., Pettis, R.M., Mhatre, A.N. & Lalwani, A.K. Safety of adeno-associated virus as cochlear gene transfer vector: analysis of distant spread beyond injected cochleae. Mol. Ther. 4, 368–373 (2000).
Bedrosian, J.C. et al. In vivo delivery of recombinant viruses to the fetal murine cochlea: transduction characteristics and long-term effects on auditory function. Mol. Ther. 14, 328–335 (2006).
Wang, L., Jiang, H. & Brigande, J.V. Gene transfer to the developing mouse inner ear by in vivo electroporation. J. Vis. Exp. 64, 3653 (2012).
Depreux, F.F. et al. Antisense oligonucleotides delivered to the amniotic cavity in utero modulate gene expression in the postnatal mouse. Nucleic Acids Res. 44, 9519–9529 (2016).
Clark, K.R., Sferra, T.J. & Johnson, P.R. Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Hum. Gene Ther. 8, 659–669 (1997).
Duan, D. et al. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 72, 8568–8577 (1998).
Noben-Trauth, K., Zheng, Q.Y. & Johnson, K.R. Association of cadherin 23 with polygenic inheritance and genetic modification of sensorineural hearing loss. Nat. Genet. 35, 21–23 (2003).
Kane, K.L. et al. Genetic background effects on age-related hearing loss associated with Cdh23 variants in mice. Hear. Res. 283, 80–88 (2012).
Lelli, A., Asai, Y., Forge, A., Holt, J.R. & Géléoc, G.S. Tonotopic gradient in the developmental acquisition of sensory transduction in outer hair cells of the mouse cochlea. J. Neurophysiol. 101, 2961–2973 (2009).
Stauffer, E.A. & Holt, J.R. Sensory transduction and adaptation in inner and outer hair cells of the mouse auditory system. J. Neurophysiol. 98, 3360–3369 (2007).
Zheng, L., Zheng, J., Whitlon, D.S., García-Añoveros, J. & Bartles, J.R. Targeting of the hair cell proteins cadherin 23, harmonin, myosin XVa, espin, and prestin in an epithelial cell model. J. Neurosci. 30, 7187–7201 (2010).